業績

2015年

  1. Okano K, Kimura K, Tanaka Y, Tsuchiya K, Akiba T, Nitta K. Direct measurement of reactive oxygen species in leukocytes during hemodialysis therapy. Int J Clin Exp Med. 2015 Nov 15;8(11):20959-64.
  2. Inoue T, Okano K, Tsuruta Y, Tsuruta Y, Tsuchiya K, Akiba T, Nitta K. Eicosapentaenoic Acid (EPA) Decreases the All-Cause Mortality in Hemodialysis Patients. Intern Med. 2015;54(24):3133-7.
  3. Shimizu A, Takei T, Moriyama T, Itabashi M, Uchida K, Nitta K. Effect of Pregnancy and Delivery on the Renal Function and the Prognosis of Patients with Chronic Kidney Disease Stage 3 Caused by Immunoglobulin A Nephropathy. Intern Med. 2015;54(24):3127-32.
  4. Kimata N, Tsuchiya K, Akiba T, Nitta K. Differences in the Characteristics of Dialysis Patients in Japan Compared with Those in Other Countries. Blood Purif. 2015 Nov 17;40(4):275-279.
  5. Yokoyama T, Nitta K. [Recent Advances in Urinalysis as a Diagnostic Indicator of Renal Diseases]. Rinsho Byori. 2015 Feb;63(2):252-8.
  6. Kataoka H, Tsuchiya K, Naganuma T, Okazaki M, Komatsu M, Kimura T, Shiohira S, Kawaguchi H, Nitta K.　Relationship between anaemia management at haemodialysis initiation and patient prognosis.　 Nephrology (Carlton). 2015 Dec; 20 Suppl 4:14-21.
  7. Takura T, Nakanishi T, Kawanishi H, Nitta K, Akizawa T, Hiramatsu M, Kawasaki T, Kukita K, Soejima H, Hirakata H, Yoshida T, Miyamoto T, Takahashi S. Cost-Effectiveness of Maintenance Hemodialysis in Japan. Ther Apher Dial. 2015 Oct;19(5):441-9.
  8. Manabe S, Hatano M, Yazaki M, Nitta K, Nagata M. Renal AH Amyloidosis Associated With a Truncated Immunoglobulin Heavy Chain Undetectable by Immunostaining. Am J Kidney Dis. 2015 Dec;66(6):1095-100.
  9. Taneda S, Honda K, Ohno M, Uchida K, Nitta K, Oda H. Podocyte and endothelial injury in focal segmental glomerulosclerosis: an ultrastructural analysis. Virchows Arch. 2015 Oct;467(4):449-58.
  10. Nitta K. Chronic Kidney Diseases ? Recent Advances in Clinical and Basic Research. Preface. Contrib Nephrol. 2015;185: VII-XI.
  11. Nokiba H, Takei T, Suto C, Nitta K. Association between Ophthalmological Changes and Cardiovascular Diseases in Patients with Chronic Kidney Disease Undergoing Hemodialysis. J Atheroscler Thromb. 2015;22(12):1248-54.
  12. Unagami K, Kawanishi K, Shimizu T, Kanzawa T, Toki D, Okumi M, Omoto K, Horita S, Koike J, Honda K, Nagashima Y, Ishida H, Tanabe K, Nitta K. A case of recurrent focal segmental glomerulosclerosis after kidney transplantation associated with variant conversion in the Columbia classification. Nephrology (Carlton). 2015 Jul;20 Suppl 2:96-100.
  13. Kawaguchi K, Kawanishi K, Sato M, Itabashi M, Fujii A, Kanetsuna Y, Huchinoue S, Ohashi R, Koike J, Honda K, Nagashima Y, Nitta K. Atypical hemolytic uremic syndrome diagnosed four years after ABO-incompatible kidney transplantation. Nephrology (Carlton). 2015 Jul;20 Suppl 2:61-5.
  14. Nitta K, Ogawa T. Vascular calcification in end-stage renal disease patients. Contrib Nephrol. 2015;185:156-67.
  15. Ogawa T, Nitta K. Erythropoiesis-stimulating agent hyporesponsiveness in end-stage renal disease patients. Contrib Nephrol. 2015;185:76-86. Kawanishi K, Nitta K. Cell sheet-based tissue engineering for mesothelial cell injury. Contrib Nephrol. 2015;185:66-75.
  16. Tsuchiya K, Nagano N, Nitta K. Klotho/FGF23 Axis in CKD. Contrib Nephrol. 2015;185:56-65.
  17. Tsuruta Y, Kikuchi K, Tsuruta Y, Sasaki Y, Moriyama T, Itabashi M, Takei T, Uchida K, Akiba T, Tsuchiya K, Nitta K. Febuxostat improves endothelial function in hemodialysis patients with hyperuricemia: A randomized controlled study. Hemodial Int. 2015 Oct;19(4):514-20.
  18. Komatsu M, Okazaki M, Tsuchiya K, Kawaguchi H, Nitta K. Geriatric Nutritional Risk Index Is a Simple Predictor of Mortality in Chronic Hemodialysis Patients. Blood Purif. 2015;39(4):281-7.
  19. Ogawa T, Koeda M, Nitta K. Left Ventricular Diastolic Dysfunction in End-Stage Kidney Disease: Pathogenesis, Diagnosis, and Treatment. Ther Apher Dial. 2015 Oct;19(5):427-35.
  20. Manabe S, Banno M, Nakano M, Fujii T, Fujiwara M, Kita Y, Nitta K, Hatano M. Bucillamine-induced membranous nephropathy with crescent formation in a patient with rheumatoid arthritis: case report and literature review. Case Rep Nephrol Dial. 2014 Oct 29;5(1):30-8.
  21. Nitta K, Okada K, Yanai M, Takahashi S. The Kidney Early Evaluation Program (KEEP) of Japan. Clin Nephrol. 2015;83(7 Suppl 1):52-5. PMID: 25725243
  22. Tsuchiya M, Misaka R, Nitta K, Tsuchiya K. Transcriptional factors, Mafs and their biological roles. World J Diabetes. 2015 Feb 15;6(1):175-83.
  23. Hoshino Y, Kaga T, Abe Y, Endo M, Wakai S, Tsuchiya K, Nitta K. Renal biopsy findings and clinical indicators of patients with hematuria without overt proteinuria. Clin Exp Nephrol. 2015 Oct;19(5):918-24.
  24. Moriyama T, Takei T, Itabashi M, Uchida K, Tsuchiya K, Nitta K. Caveolae may enable albumin to enter human renal glomerular endothelial cells. J Cell Biochem. 2015 Jun;116(6):1060-9.
  25. Hirayama K, Kobayashi M, Usui J, Arimura Y, Sugiyama H, Nitta K, Muso E, Wada T, Matsuo S, Yamagata K; Japanese RPGN Study Group of Progressive Renal Disease. Pulmonary involvements of anti-neutrophil cytoplasmi autoantibody-associated renal vasculitis in Japan. Nephrol Dial Transplant. 2015 Apr;30 Suppl 1:i83-93.
  26. Tanaka K, Moriyama T, Iwasaki C, Takei T, Nitta K. Effect of hematuria on the outcome of IgA nephropathy with mild proteinuria. Clin Exp Nephrol. 2015 Oct;19(5):815-21.
  27. Hara M, Ando M, Tsuchiya K, Nitta K. Serum hepcidin-25 level linked with high mortality in patients with non-Hodgkin lymphoma. Ann Hematol. 2015 Apr;94(4):603-8.
  28. Nitta K, Nagano N, Tsuchiya K. Fibroblast growth factor 23/klotho axis in chronic kidney disease. Nephron Clin Pract. 2014;128(1-2):1-10.
  29. Hirose O, Itabashi M, Takei T, Nitta K. Comparison of a novel chemiluminescence enzyme immunoassay (CLEIA) with enzyme-linked immunosorbent assay (ELISA) for the determination of MPO-ANCA in patients with ANCA-associated vasculitis. Mod Rheumatol. 2015 Mar;25(2):230-4.
  30. Oshima Y, Moriyama T, Itabashi M, Takei T, Nitta K. Characteristics of IgA nephropathy in advanced-age patients. Int Urol Nephrol. 2015 Jan;47(1):137-45.
  31. Saito T, Uchida K, Ishida H, Tanabe K, Nitta K. Changes in glomerular filtration rate after donation in living kidney donors: a single-center cohort study. Int Urol Nephrol. 2015 Feb;47(2):397-403.
  32. Moriyama T, Itabashi M, Takei T, Kataoka H, Sato M, Shimizu A, Iwabuchi Y, Nishida M, Uchida K, Nitta K. High uric acid level is a risk factor for progression of IgA nephropathy with chronic kidney disease stage G3a. J Nephrol. 2015 Aug;28(4):451-6.
  33. Karasawa K, Asano K, Moriyama S, Ushiki M, Monya M, Iida M, Kuboki E, Yagita H, Uchida K, Nitta K, Tanaka M. Vascular-resident CD169-positive monocytes and macrophages control neutrophil accumulation in the kidney with ischemia-reperfusion injury. J Am Soc Nephrol. 2015 Apr;26(4):896-906.
  34. Kawanishi K, Nitta K, Yamato M, Okano T. Therapeutic applications of mesothelial cell sheets. Ther Apher Dial. 2015 Feb;19(1):1-7.
  35. Iimuro S, Imai E, Watanabe T, Nitta K, Akizawa T, Matsuo S, Makino H, Ohashi Y, Hishida A. Hyperbaric area index calculated from ABPM elucidates the condition of CKD patients: the CKD-JAC study. Clin Exp Nephrol. 2015 Feb;19(1):114-24.